English

MERA PHARMACEUTICALS INC

EDGAR

Annual report (10-K) · filed 2013-07-23

76 filing records in this dataset, filed from 1996-03-18 to 2013-07-23. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

67.1 thousand USD

2010-07-31 · USD

Exact inputs and evidence

Revenue: 67115 USD Source

Operating margin

-78.34%

2010-07-31 · %

Exact inputs and evidence

Operating Income: -52580 USD Source
Revenue: 67115 USD Source

Operating cash flow

-2.35 thousand USD

2010-07-31 · USD

Exact inputs and evidence

Operating Cash Flow: 147715 USD Source
Operating Cash Flow: 150065 USD Source

Cash and cash equivalents: 850 USD 2010-07-31 Source
Exact value

850 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

323 thousand USD

2009-08-01 – 2010-07-31

Exact inputs and evidence

Revenue: 599091 USD · 2008-11-01 – 2009-10-31 Source
Revenue: 500912 USD · 2008-11-01 – 2009-07-31 Source
Revenue: 96215 USD · 2009-11-01 – 2010-01-31 Source
Revenue: 61413 USD · 2010-02-01 – 2010-04-30 Source
Revenue: 67115 USD · 2010-05-01 – 2010-07-31 Source

Net income

-244 thousand USD

2009-08-01 – 2010-07-31

Exact inputs and evidence

Net income: -192878 USD · 2008-11-01 – 2009-10-31 Source
Net income: -92468 USD · 2008-11-01 – 2009-07-31 Source
Net income: -17390 USD · 2009-11-01 – 2010-01-31 Source
Net income: -77778 USD · 2010-02-01 – 2010-04-30 Source
Net income: -48118 USD · 2010-05-01 – 2010-07-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-07-23.

Financial data available through: 2009-10-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2009-10-31
Operating income: 11 of 11 periods available· newest 2009-10-31
Net income: 11 of 11 periods available· newest 2009-10-31
Operating cash flow: 11 of 11 periods available· newest 2009-10-31
capital expenditure: No compatible figures in this window
Total assets: 10 of 11 periods available· newest 2009-10-31
liabilities: No compatible figures in this window
Current assets: 10 of 11 periods available· newest 2009-10-31
Current liabilities: 10 of 11 periods available· newest 2009-10-31
Cash and cash equivalents: 10 of 11 periods available· newest 2009-10-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-1.8%

Prior period

USD 609,984

2007-11-01 – 2008-10-31
Current period

USD 599,091

2008-11-01 – 2009-10-31

Exact inputs and evidence

599091 − 609984 = -10893 USD

609984 USD · 2007-11-01 – 2008-10-31
Inspect prior input Prior source
599091 USD · 2008-11-01 – 2009-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MERA PHARMACEUTICALS INC · 2009-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Year-over-year change in Revenue: -10893 USD Concept: fundies:Revenue Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 599091 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#6000 Input fundies:Revenue: 609984 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#6000
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.75 million

Prior period

−USD 1.95 million

2007-11-01 – 2008-10-31
Current period

−USD 192,878

2008-11-01 – 2009-10-31

Exact inputs and evidence

-192878 − -1945356 = 1752478 USD

-1945356 USD · 2007-11-01 – 2008-10-31
Inspect prior input Prior source
-192878 USD · 2008-11-01 – 2009-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MERA PHARMACEUTICALS INC · 2009-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Year-over-year change in Net income: 1752478 USD Concept: fundies:NetIncome Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -192878 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7450 Input fundies:NetIncome: -1945356 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7450
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 92,140

Prior period

−USD 118,591

2007-11-01 – 2008-10-31
Current period

−USD 26,451

2008-11-01 – 2009-10-31

Exact inputs and evidence

-26451 − -118591 = 92140 USD

-118591 USD · 2007-11-01 – 2008-10-31
Inspect prior input Prior source
-26451 USD · 2008-11-01 – 2009-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MERA PHARMACEUTICALS INC · 2009-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Year-over-year change in Operating cash flow: 92140 USD Concept: fundies:OperatingCashFlow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -26451 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7584 Input fundies:OperatingCashFlow: -118591 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7584
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2008-11-01 – 2009-10-31

Revenue USD 599,091 100% of revenue
Cost of revenue USD 28,021 4.7% of revenue
Operating expenses USD 793,335 132% of revenue
Operating income −USD 222,265 −37% of revenue
Tax, interest and other Derived −USD 29,387 −4.9% of revenue
Net income −USD 192,878 −32% of revenue

Cash

Operating cash flow −USD 26,451 −4.4% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 467% of revenue.
2002 Operating loss: operating costs were 390% of revenue.
2002 Operating loss: operating costs were 1,186% of revenue.
2003 Operating loss: operating costs were 362% of revenue.
2004 Operating loss: operating costs were 250% of revenue.
2005 Operating loss: operating costs were 439% of revenue.
2006 Operating loss: operating costs were 234% of revenue.
2007 Operating loss: operating costs were 170% of revenue.
2008 Operating loss: operating costs were 424% of revenue.
2009 Operating loss: operating costs were 137% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2000-11-01 – 2001-10-31	1032644	4823655 Derived	-3791011	300560 Derived	-4091571	Unavailable	Source 2000-11-01 – 2001-10-31: 1032644 USD Inspect Revenue Open source 2000-11-01 – 2001-10-31: -3791011 USD Inspect Operating Income Open source 2000-11-01 – 2001-10-31: -4091571 USD Inspect Net Income Open source 2000-11-01 – 2001-10-31: -3036788 USD Inspect Operating Cash Flow Open source
2002 2001-09-17 – 2002-09-16	613502	2391979 Derived	-1778477	69671 Derived	-1848148	Unavailable	Source 2001-09-17 – 2002-09-16: 613502 USD Inspect Revenue Open source 2001-09-17 – 2002-09-16: -1778477 USD Inspect Operating Income Open source 2001-09-17 – 2002-09-16: -1848148 USD Inspect Net Income Open source
2002 2001-11-01 – 2002-10-31	48570	575994 Derived	-527424	14466 Derived	-541890	Unavailable	Source 2001-11-01 – 2002-10-31: 48570 USD Inspect Revenue Open source 2001-11-01 – 2002-10-31: -527424 USD Inspect Operating Income Open source 2001-11-01 – 2002-10-31: -541890 USD Inspect Net Income Open source 2001-11-01 – 2002-10-31: -377151 USD Inspect Operating Cash Flow Open source
2003 2002-11-01 – 2003-10-31	776109	2810365 Derived	-2034256	-202399 Derived	-1831857	Unavailable	Source 2002-11-01 – 2003-10-31: 776109 USD Inspect Revenue Open source 2002-11-01 – 2003-10-31: -2034256 USD Inspect Operating Income Open source 2002-11-01 – 2003-10-31: -1831857 USD Inspect Net Income Open source 2002-11-01 – 2003-10-31: -1087733 USD Inspect Operating Cash Flow Open source
2004 2003-11-01 – 2004-10-31	909613	2270104 Derived	-1360491	-255940 Derived	-1104551	Unavailable	Source 2003-11-01 – 2004-10-31: 909613 USD Inspect Revenue Open source 2003-11-01 – 2004-10-31: -1360491 USD Inspect Operating Income Open source 2003-11-01 – 2004-10-31: -1104551 USD Inspect Net Income Open source 2003-11-01 – 2004-10-31: -1249081 USD Inspect Operating Cash Flow Open source
2005 2004-11-01 – 2005-10-31	387972	1701370 Derived	-1313398	-7694 Derived	-1305704	Unavailable	Source 2004-11-01 – 2005-10-31: 387972 USD Inspect Revenue Open source 2004-11-01 – 2005-10-31: -1313398 USD Inspect Operating Income Open source 2004-11-01 – 2005-10-31: -1305704 USD Inspect Net Income Open source 2004-11-01 – 2005-10-31: -567493 USD Inspect Operating Cash Flow Open source
2006 2005-11-01 – 2006-10-31	386757	904877 Derived	-518120	-9713 Derived	-508407	Unavailable	Source 2005-11-01 – 2006-10-31: 386757 USD Inspect Revenue Open source 2005-11-01 – 2006-10-31: -518120 USD Inspect Operating Income Open source 2005-11-01 – 2006-10-31: -508407 USD Inspect Net Income Open source 2005-11-01 – 2006-10-31: -202674 USD Inspect Operating Cash Flow Open source
2007 2006-11-01 – 2007-10-31	470379	801282 Derived	-330903	-8637 Derived	-322266	Unavailable	Source 2006-11-01 – 2007-10-31: 470379 USD Inspect Revenue Open source 2006-11-01 – 2007-10-31: -330903 USD Inspect Operating Income Open source 2006-11-01 – 2007-10-31: -322266 USD Inspect Net Income Open source 2006-11-01 – 2007-10-31: -45823 USD Inspect Operating Cash Flow Open source
2008 2007-11-01 – 2008-10-31	609984	2588747 Derived	-1978763	-33407 Derived	-1945356	Unavailable	Source 2007-11-01 – 2008-10-31: 609984 USD Inspect Revenue Open source 2007-11-01 – 2008-10-31: -1978763 USD Inspect Operating Income Open source 2007-11-01 – 2008-10-31: -1945356 USD Inspect Net Income Open source 2007-11-01 – 2008-10-31: -118591 USD Inspect Operating Cash Flow Open source
2009 2008-11-01 – 2009-10-31	599091	821356 Derived	-222265	-29387 Derived	-192878	Unavailable	Source 2008-11-01 – 2009-10-31: 599091 USD Inspect Revenue Open source 2008-11-01 – 2009-10-31: -222265 USD Inspect Operating Income Open source 2008-11-01 – 2009-10-31: -192878 USD Inspect Net Income Open source 2008-11-01 – 2009-10-31: -26451 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 599.1K 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Revenue	1032644	Revenue: 1032644 Open source
20022002-09-16	Revenue	613502	Revenue: 613502 Open source
20022002-10-31	Revenue	48570	Revenue: 48570 Open source
20032003-10-31	Revenue	776109	Revenue: 776109 Open source
20042004-10-31	Revenue	909613	Revenue: 909613 Open source
20052005-10-31	Revenue	387972	Revenue: 387972 Open source
20062006-10-31	Revenue	386757	Revenue: 386757 Open source
20072007-10-31	Revenue	470379	Revenue: 470379 Open source
20082008-10-31	Revenue	609984	Revenue: 609984 Open source
20092009-10-31	Revenue	599091	Revenue: 599091 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-1.8% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Year over year	No prior comparable period	Revenue: 1032644 Open source Revenue: 0 Open source
20022002-09-16	Year over year	No prior comparable period	Revenue: 613502 Open source
20022002-10-31	Year over year	-95.3%	Revenue: 48570 Open source Revenue: 1032644 Open source
20032003-10-31	Year over year	1,497.9%	Revenue: 776109 Open source Revenue: 48570 Open source
20042004-10-31	Year over year	17.2%	Revenue: 909613 Open source Revenue: 776109 Open source
20052005-10-31	Year over year	-57.3%	Revenue: 387972 Open source Revenue: 909613 Open source
20062006-10-31	Year over year	-0.3%	Revenue: 386757 Open source Revenue: 387972 Open source
20072007-10-31	Year over year	21.6%	Revenue: 470379 Open source Revenue: 386757 Open source
20082008-10-31	Year over year	29.7%	Revenue: 609984 Open source Revenue: 470379 Open source
20092009-10-31	Year over year	-1.8%	Revenue: 599091 Open source Revenue: 609984 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -37.1% 2009

Net margin -32.2% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Operating margin	-367.1%	Operating Income: -3791011 Open source Revenue: 1032644 Open source
20022002-09-16	Operating margin	-289.9%	Operating Income: -1778477 Open source Revenue: 613502 Open source
20022002-10-31	Operating margin	-1,085.9%	Operating Income: -527424 Open source Revenue: 48570 Open source
20032003-10-31	Operating margin	-262.1%	Operating Income: -2034256 Open source Revenue: 776109 Open source
20042004-10-31	Operating margin	-149.6%	Operating Income: -1360491 Open source Revenue: 909613 Open source
20052005-10-31	Operating margin	-338.5%	Operating Income: -1313398 Open source Revenue: 387972 Open source
20062006-10-31	Operating margin	-134%	Operating Income: -518120 Open source Revenue: 386757 Open source
20072007-10-31	Operating margin	-70.3%	Operating Income: -330903 Open source Revenue: 470379 Open source
20082008-10-31	Operating margin	-324.4%	Operating Income: -1978763 Open source Revenue: 609984 Open source
20092009-10-31	Operating margin	-37.1%	Operating Income: -222265 Open source Revenue: 599091 Open source
20012001-10-31	Net margin	-396.2%	Net Income: -4091571 Open source Revenue: 1032644 Open source
20022002-09-16	Net margin	-301.2%	Net Income: -1848148 Open source Revenue: 613502 Open source
20022002-10-31	Net margin	-1,115.7%	Net Income: -541890 Open source Revenue: 48570 Open source
20032003-10-31	Net margin	-236%	Net Income: -1831857 Open source Revenue: 776109 Open source
20042004-10-31	Net margin	-121.4%	Net Income: -1104551 Open source Revenue: 909613 Open source
20052005-10-31	Net margin	-336.5%	Net Income: -1305704 Open source Revenue: 387972 Open source
20062006-10-31	Net margin	-131.5%	Net Income: -508407 Open source Revenue: 386757 Open source
20072007-10-31	Net margin	-68.5%	Net Income: -322266 Open source Revenue: 470379 Open source
20082008-10-31	Net margin	-318.9%	Net Income: -1945356 Open source Revenue: 609984 Open source
20092009-10-31	Net margin	-32.2%	Net Income: -192878 Open source Revenue: 599091 Open source
20012001-10-31	Free cash flow margin	Not reported	Revenue: 1032644 Open source Operating Cash Flow: -3036788 Open source
20022002-09-16	Free cash flow margin	Not reported	Revenue: 613502 Open source
20022002-10-31	Free cash flow margin	Not reported	Revenue: 48570 Open source Operating Cash Flow: -377151 Open source
20032003-10-31	Free cash flow margin	Not reported	Revenue: 776109 Open source Operating Cash Flow: -1087733 Open source
20042004-10-31	Free cash flow margin	Not reported	Revenue: 909613 Open source Operating Cash Flow: -1249081 Open source
20052005-10-31	Free cash flow margin	Not reported	Revenue: 387972 Open source Operating Cash Flow: -567493 Open source
20062006-10-31	Free cash flow margin	Not reported	Revenue: 386757 Open source Operating Cash Flow: -202674 Open source
20072007-10-31	Free cash flow margin	Not reported	Revenue: 470379 Open source Operating Cash Flow: -45823 Open source
20082008-10-31	Free cash flow margin	Not reported	Revenue: 609984 Open source Operating Cash Flow: -118591 Open source
20092009-10-31	Free cash flow margin	Not reported	Revenue: 599091 Open source Operating Cash Flow: -26451 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -26.5K 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Operating cash flow	-3036788	Operating Cash Flow: -3036788 Open source
20022002-09-16	Operating cash flow	Not reported	No source recorded
20022002-10-31	Operating cash flow	-377151	Operating Cash Flow: -377151 Open source
20032003-10-31	Operating cash flow	-1087733	Operating Cash Flow: -1087733 Open source
20042004-10-31	Operating cash flow	-1249081	Operating Cash Flow: -1249081 Open source
20052005-10-31	Operating cash flow	-567493	Operating Cash Flow: -567493 Open source
20062006-10-31	Operating cash flow	-202674	Operating Cash Flow: -202674 Open source
20072007-10-31	Operating cash flow	-45823	Operating Cash Flow: -45823 Open source
20082008-10-31	Operating cash flow	-118591	Operating Cash Flow: -118591 Open source
20092009-10-31	Operating cash flow	-26451	Operating Cash Flow: -26451 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Free cash flow	Unavailable	Operating Cash Flow: -3036788 Open source
20022002-09-16	Free cash flow	Unavailable	No source recorded
20022002-10-31	Free cash flow	Unavailable	Operating Cash Flow: -377151 Open source
20032003-10-31	Free cash flow	Unavailable	Operating Cash Flow: -1087733 Open source
20042004-10-31	Free cash flow	Unavailable	Operating Cash Flow: -1249081 Open source
20052005-10-31	Free cash flow	Unavailable	Operating Cash Flow: -567493 Open source
20062006-10-31	Free cash flow	Unavailable	Operating Cash Flow: -202674 Open source
20072007-10-31	Free cash flow	Unavailable	Operating Cash Flow: -45823 Open source
20082008-10-31	Free cash flow	Unavailable	Operating Cash Flow: -118591 Open source
20092009-10-31	Free cash flow	Unavailable	Operating Cash Flow: -26451 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-10-31	Liabilities / assets	Not reported	Total Assets: 4138604 Open source
2002-09-16	Liabilities / assets	Not reported	No source recorded
2002-10-31	Liabilities / assets	Not reported	Total Assets: 5520536 Open source
2003-10-31	Liabilities / assets	Not reported	Total Assets: 4266894 Open source
2004-10-31	Liabilities / assets	Not reported	Total Assets: 3277494 Open source
2005-10-31	Liabilities / assets	Not reported	Total Assets: 2614870 Open source
2006-10-31	Liabilities / assets	Not reported	Total Assets: 2432737 Open source
2007-10-31	Liabilities / assets	Not reported	Total Assets: 2226085 Open source
2008-10-31	Liabilities / assets	Not reported	Total Assets: 394714 Open source
2009-10-31	Liabilities / assets	Not reported	Total Assets: 257496 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.14× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Current assets / current liabilities	0.15×	Current Assets: 688810 Open source Current Liabilities: 4596551 Open source
2002-09-16	Current assets / current liabilities	Not reported	No source recorded
20022002-10-31	Current assets / current liabilities	0.46×	Current Assets: 2248218 Open source Current Liabilities: 4879153 Open source
20032003-10-31	Current assets / current liabilities	0.47×	Current Assets: 1062816 Open source Current Liabilities: 2284275 Open source
20042004-10-31	Current assets / current liabilities	1.23×	Current Assets: 415462 Open source Current Liabilities: 336990 Open source
20052005-10-31	Current assets / current liabilities	0.06×	Current Assets: 20899 Open source Current Liabilities: 378990 Open source
20062006-10-31	Current assets / current liabilities	0.1×	Current Assets: 41650 Open source Current Liabilities: 437533 Open source
20072007-10-31	Current assets / current liabilities	0.09×	Current Assets: 38997 Open source Current Liabilities: 411928 Open source
20082008-10-31	Current assets / current liabilities	0.33×	Current Assets: 113275 Open source Current Liabilities: 340938 Open source
20092009-10-31	Current assets / current liabilities	0.14×	Current Assets: 57014 Open source Current Liabilities: 396598 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2000-11-01 – 2001-10-31	−USD 4.09 million Exact value Exact value: -4091571 USD 2000-11-01 – 2001-10-31: -4091571 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2001-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -4091571 USD Concept: fundies:NetIncome Period: 2000-11-01 to 2001-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2001-10-31&surface=latest&period_type=duration&start=2000-11-01&unit=USD&dimensions= Input fundies:NetIncome: -4091571 USD (2000-11-01 to 2001-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-02-000119.txt#3944 The citation records this snapshot. The page link may show a newer release later.	−USD 3.04 million Exact value Exact value: -3036788 USD 2000-11-01 – 2001-10-31: -3036788 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2001-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -3036788 USD Concept: fundies:OperatingCashFlow Period: 2000-11-01 to 2001-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2001-10-31&surface=latest&period_type=duration&start=2000-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3036788 USD (2000-11-01 to 2001-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-02-000119.txt#3959 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2001-09-17 – 2002-09-16	−USD 1.85 million Exact value Exact value: -1848148 USD 2001-09-17 – 2002-09-16: -1848148 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2002-09-16 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -1848148 USD Concept: fundies:NetIncome Period: 2001-09-17 to 2002-09-16 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2002-09-16&surface=latest&period_type=duration&start=2001-09-17&unit=USD&dimensions= Input fundies:NetIncome: -1848148 USD (2001-09-17 to 2002-09-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-03-000155.txt#444 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2002 2001-11-01 – 2002-10-31	−USD 541,890 Exact value Exact value: -541890 USD 2001-11-01 – 2002-10-31: -541890 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2002-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -541890 USD Concept: fundies:NetIncome Period: 2001-11-01 to 2002-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2002-10-31&surface=latest&period_type=duration&start=2001-11-01&unit=USD&dimensions= Input fundies:NetIncome: -541890 USD (2001-11-01 to 2002-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-04-000097.txt#3478 The citation records this snapshot. The page link may show a newer release later.	−USD 377,151 Exact value Exact value: -377151 USD 2001-11-01 – 2002-10-31: -377151 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2002-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -377151 USD Concept: fundies:OperatingCashFlow Period: 2001-11-01 to 2002-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2002-10-31&surface=latest&period_type=duration&start=2001-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -377151 USD (2001-11-01 to 2002-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-04-000097.txt#3494 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2002-11-01 – 2003-10-31	−USD 1.83 million Exact value Exact value: -1831857 USD 2002-11-01 – 2003-10-31: -1831857 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2003-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -1831857 USD Concept: fundies:NetIncome Period: 2002-11-01 to 2003-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2003-10-31&surface=latest&period_type=duration&start=2002-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1831857 USD (2002-11-01 to 2003-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-05-000166.txt#2702 The citation records this snapshot. The page link may show a newer release later.	−USD 1.09 million Exact value Exact value: -1087733 USD 2002-11-01 – 2003-10-31: -1087733 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2003-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -1087733 USD Concept: fundies:OperatingCashFlow Period: 2002-11-01 to 2003-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2003-10-31&surface=latest&period_type=duration&start=2002-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1087733 USD (2002-11-01 to 2003-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-05-000166.txt#2718 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2003-11-01 – 2004-10-31	−USD 1.1 million Exact value Exact value: -1104551 USD 2003-11-01 – 2004-10-31: -1104551 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2004-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -1104551 USD Concept: fundies:NetIncome Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1104551 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-06-000210.txt#2729 The citation records this snapshot. The page link may show a newer release later.	−USD 1.25 million Exact value Exact value: -1249081 USD 2003-11-01 – 2004-10-31: -1249081 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2004-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -1249081 USD Concept: fundies:OperatingCashFlow Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1249081 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0000909012-06-000210.txt#2744 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2004-11-01 – 2005-10-31	−USD 1.31 million Exact value Exact value: -1305704 USD 2004-11-01 – 2005-10-31: -1305704 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2005-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -1305704 USD Concept: fundies:NetIncome Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1305704 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-07-000179.txt#1952 The citation records this snapshot. The page link may show a newer release later.	−USD 567,493 Exact value Exact value: -567493 USD 2004-11-01 – 2005-10-31: -567493 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2005-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -567493 USD Concept: fundies:OperatingCashFlow Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -567493 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-07-000179.txt#1998 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2005-11-01 – 2006-10-31	−USD 508,407 Exact value Exact value: -508407 USD 2005-11-01 – 2006-10-31: -508407 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2006-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -508407 USD Concept: fundies:NetIncome Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:NetIncome: -508407 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-08-000264.txt#1653 The citation records this snapshot. The page link may show a newer release later.	−USD 202,674 Exact value Exact value: -202674 USD 2005-11-01 – 2006-10-31: -202674 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2006-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -202674 USD Concept: fundies:OperatingCashFlow Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -202674 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-08-000197.txt#1875 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2006-11-01 – 2007-10-31	−USD 322,266 Exact value Exact value: -322266 USD 2006-11-01 – 2007-10-31: -322266 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2007-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -322266 USD Concept: fundies:NetIncome Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:NetIncome: -322266 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-09-000070.txt#2444 The citation records this snapshot. The page link may show a newer release later.	−USD 45,823 Exact value Exact value: -45823 USD 2006-11-01 – 2007-10-31: -45823 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2007-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -45823 USD Concept: fundies:OperatingCashFlow Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45823 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-09-000070.txt#2544 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-11-01 – 2008-10-31	−USD 1.95 million Exact value Exact value: -1945356 USD 2007-11-01 – 2008-10-31: -1945356 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2008-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -1945356 USD Concept: fundies:NetIncome Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1945356 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7450 The citation records this snapshot. The page link may show a newer release later.	−USD 118,591 Exact value Exact value: -118591 USD 2007-11-01 – 2008-10-31: -118591 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2008-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -118591 USD Concept: fundies:OperatingCashFlow Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -118591 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7584 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-11-01 – 2009-10-31	−USD 192,878 Exact value Exact value: -192878 USD 2008-11-01 – 2009-10-31: -192878 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERA PHARMACEUTICALS INC · 2009-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Net Income: -192878 USD Concept: fundies:NetIncome Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3ANetIncome&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:NetIncome: -192878 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7450 The citation records this snapshot. The page link may show a newer release later.	−USD 26,451 Exact value Exact value: -26451 USD 2008-11-01 – 2009-10-31: -26451 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERA PHARMACEUTICALS INC · 2009-10-31 MERA PHARMACEUTICALS INC (edgar:837490) Operating Cash Flow: -26451 USD Concept: fundies:OperatingCashFlow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/837490/explain?concept=fundies%3AOperatingCashFlow&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26451 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/837490/0001354488-10-000150.txt#7584 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

76 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0000837490, 837490, edgar:837490

Also known as AQUASEARCH INC

MERA PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2009 2008-11-01 – 2009-10-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation